Skip to main content

Peer Review reports

From: Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell

Original Submission
7 Dec 2017 Submitted Original manuscript
31 May 2018 Author responded Author comments - Sainan Zeng
31 Jan 2018 Reviewed Reviewer Report - Giuliana Cavalloni
11 Jan 2018 Reviewed Reviewer Report - Darrell Borger
21 Jan 2018 Reviewed Reviewer Report - Nisana Namwat
Resubmission - Version 2
31 May 2018 Submitted Manuscript version 2
6 Aug 2018 Author responded Author comments - Sainan Zeng
19 Jun 2018 Reviewed Reviewer Report - Giuliana Cavalloni
15 Jun 2018 Reviewed Reviewer Report - Darrell Borger
13 Jun 2018 Reviewed Reviewer Report - Nisana Namwat
Resubmission - Version 3
6 Aug 2018 Submitted Manuscript version 3
6 Sep 2018 Author responded Author comments - Sainan Zeng
Resubmission - Version 4
6 Sep 2018 Submitted Manuscript version 4
Publishing
10 Sep 2018 Editorially accepted
6 Nov 2018 Article published 10.1186/s12876-018-0870-3

You can find further information about peer review here.

Back to article page